Chair(s)
Mr Paul Sinclair, FIP President, Australia & Ms Stine Hasling Mogensen, Chairman of Pharmadanmark, Denmark & Mr Jesper Gulev Larsen, President of the Association of Danish Pharmacies, Denmark
Introduction:
This opening plenary will focus on antimicrobial resistance (AMR) as a pressing global health challenge and will explore its broader implications for healthcare transformation. Addressing both the public health threat and the socio-economic aspects of AMR, the session will consider how health systems can respond more effectively through collaboration, innovation, and strategic action. It will set the foundation for discussions throughout the congress on advancing pharmacy's contribution to improved health outcomes worldwide.
Programme:
| 09:00 – 09:10 | Welcome by the chairs |
| 09:10 – 09:20 | Opening remarks |
| Ms Sophie Løhde, Minister of Interior and Health, Denmark | |
| 09:20 – 09:50 | The global threat of antimicrobial resistance (AMR) |
| Mr Rasmus Prior Gjesing, World Health Organisation (WHO) Europe, Denmark | |
| 09:50 – 10:20 | The socio-economic aspects of antimicrobial resistance (AMR) |
| Mr Michele Cecchini, Organisation for Economic Co-operation and Development (OECD), Italy | |
| 10:20 – 10:30 | Q&A and closing remarks |
Learning objectives:
1. Explore the global health implications of antimicrobial resistance (AMR) and its impact on healthcare systems.
2. Examine the socio-economic dimensions of AMR and their relevance to health policy and planning.
3. Consider strategic approaches to support health system transformation in response to AMR and emerging global health priorities.
Take home messages:
Addressing antimicrobial resistance requires sustained, coordinated efforts that consider both public health and socio-economic factors. Strengthening health systems through effective strategies and collaboration is essential to advancing global health and supporting long-term transformation.
FIP Development Goals:
To learn more about these FIP Development Goals, click on the links below.
FIP Development Goal 13: Policy Development
FIP Development Goal 17: Antimicrobial Stewardship
FIP Development Goal 21: Sustainability in Pharmacy
